Search research articles
Contact Us
Filters
Showing results (51-60 of 74) with videos related to
Page
of 8
Sort By:
Environmental Health Perspectives
|
December 4, 2003
Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors
Geary W Olsen, Timothy R Church, John P Miller, et al.
Plos Genetics
|
December 5, 2012
A genome-scale RNA-interference screen identifies RRAS signaling as a pathologic feature of Huntington's disease
John P Miller, Bridget E Yates, Ismael Al-Ramahi, et al.
Journal of Lipid Research
|
June 13, 2025
An ABCB11 variant registry and novel knockin mouse model of PFIC2 based on the clinically relevant ABCB11 E297G variant
Eric L Bell, Jennifer K Truong, Youhwa Jo, et al.
The Journal of Clinical Investigation
|
February 24, 2015
Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma
Lawrence N Kwong, Genevieve M Boland, Dennie T Frederick, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 23, 2019
Unlicensed Umbilical Cord Blood Units Provide a Safe and Effective Graft Source for a Diverse Population: A Study of 2456 Umbilical Cord Blood Recipients
Karen Ballen, Brent R Logan, Pintip Chitphakdithai, et al.
Cell Reports
|
May 24, 2016
Oncogenic BRAF-Mediated Melanoma Cell Invasion
Hezhe Lu, Shujing Liu, Gao Zhang, et al.
The New England Journal of Medicine
|
May 19, 2006
Volume progression in polycystic kidney disease
Jared J Grantham, Vicente E Torres, Arlene B Chapman, et al.
Implementation Research and Practice
|
April 24, 2023
Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model
Renee M Cloutier, Evan S Cole, Brianna L McDonough, et al.
EMBO Molecular Medicine
|
July 2, 2017
Orkambi® and amplifier co-therapy improves function from a rare <i>CFTR</i> mutation in gene-edited cells and patient tissue
Steven V Molinski, Saumel Ahmadi, Wan Ip, et al.
Transplantation and Cellular Therapy
|
April 10, 2021
Serious Adverse Events in Related Donors: A Report from the Related Donor Safe Study
Matthew D Seftel, Pintip Chitphakdithai, John P Miller, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 74) with videos related to
Sort By:
Page
of 8
Environmental Health Perspectives
|
December 4, 2003
Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors
Geary W Olsen, Timothy R Church, John P Miller, et al.
Plos Genetics
|
December 5, 2012
A genome-scale RNA-interference screen identifies RRAS signaling as a pathologic feature of Huntington's disease
John P Miller, Bridget E Yates, Ismael Al-Ramahi, et al.
Journal of Lipid Research
|
June 13, 2025
An ABCB11 variant registry and novel knockin mouse model of PFIC2 based on the clinically relevant ABCB11 E297G variant
Eric L Bell, Jennifer K Truong, Youhwa Jo, et al.
The Journal of Clinical Investigation
|
February 24, 2015
Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma
Lawrence N Kwong, Genevieve M Boland, Dennie T Frederick, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 23, 2019
Unlicensed Umbilical Cord Blood Units Provide a Safe and Effective Graft Source for a Diverse Population: A Study of 2456 Umbilical Cord Blood Recipients
Karen Ballen, Brent R Logan, Pintip Chitphakdithai, et al.
Cell Reports
|
May 24, 2016
Oncogenic BRAF-Mediated Melanoma Cell Invasion
Hezhe Lu, Shujing Liu, Gao Zhang, et al.
The New England Journal of Medicine
|
May 19, 2006
Volume progression in polycystic kidney disease
Jared J Grantham, Vicente E Torres, Arlene B Chapman, et al.
Implementation Research and Practice
|
April 24, 2023
Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model
Renee M Cloutier, Evan S Cole, Brianna L McDonough, et al.
EMBO Molecular Medicine
|
July 2, 2017
Orkambi® and amplifier co-therapy improves function from a rare <i>CFTR</i> mutation in gene-edited cells and patient tissue
Steven V Molinski, Saumel Ahmadi, Wan Ip, et al.
Transplantation and Cellular Therapy
|
April 10, 2021
Serious Adverse Events in Related Donors: A Report from the Related Donor Safe Study
Matthew D Seftel, Pintip Chitphakdithai, John P Miller, et al.
Page
of 8